Number of Clinical Trials 2009

Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.

107 data points••Global Coverage•Number of clinical trials | ClinicalTrials.gov via Our World in Data•

Newer data is available: Number of Clinical Trials by country 2024 →

Highest
United States
4,031
Lowest
Sri Lanka
1
Median country
6
Countries with data
107

Where does your country rank? Pick it to see its position.

Related Health statistics

More ↓

Interactive Map

Loading interactive map...

Complete Data Rankings

↑Top 10 Countries

  1. #1United States flagUnited States
  2. #2Canada flagCanada
  3. #3Germany flagGermany
  4. #4France flagFrance
  5. #5United Kingdom flagUnited Kingdom
  6. #6Brazil flagBrazil
  7. #7China flagChina
  8. #8Japan flagJapan
  9. #9South Korea flagSouth Korea
  10. #10Denmark flagDenmark

Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.

↓Bottom 10 Countries

  1. #107Sri Lanka flagSri Lanka
  2. #106Qatar flagQatar
  3. #105Puerto Rico flagPuerto Rico
  4. #104Mozambique flagMozambique
  5. #103Mongolia flagMongolia
  6. #102Republic of Moldova flagRepublic of Moldova
  7. #101Madagascar flagMadagascar
  8. #100Kuwait flagKuwait
  9. #99Jamaica flagJamaica
  10. #98Iraq flagIraq

Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.

Insights by country

1

Guatemala

In 2009, Guatemala ranked #95 globally with a total of 1 clinical trial. This figure is significantly lower than many of its Central American neighbors, reflecting the region's varying engagement in clinical research. Factors such as limited investment in healthcare infrastructure and a smaller population of clinical researchers contribute to Guatemala's low number of clinical trials.

2

Congo, Democratic Republic of the

In 2009, Congo, Democratic Republic of the ranked #75 globally with a total of 2 clinical trials. This figure is significantly lower than many neighboring countries, reflecting the challenges in healthcare infrastructure and research funding in the region. The limited number of clinical trials can be attributed to ongoing political instability, inadequate healthcare facilities, and a lack of investment in medical research.

3

Kuwait

Kuwait ranked #99 globally with a total of 1 clinical trial in 2009. This low number is significantly below the global average, reflecting a limited research infrastructure compared to higher-ranked countries. Factors contributing to this statistic include Kuwait's small population size and a focus on oil-based economic activities, which may divert resources away from medical research initiatives.

4

Haiti

In 2009, Haiti ranked #96 globally with a total of 1 clinical trial. This figure is significantly lower than many of its regional neighbors, indicating limited research activity in the country. Contributing factors include Haiti's ongoing economic challenges, lack of infrastructure, and political instability, which hinder the development of a robust clinical research environment.

5

Finland

In 2009, Finland ranked #25 globally with a total of 53 clinical trials. This figure is notable when compared to its Nordic neighbors, such as Sweden, which had a higher number of trials. Finland's strong healthcare system, coupled with robust government support for medical research, drives its clinical trial activity, making it an attractive location for pharmaceutical companies and researchers.

6

Colombia

In 2009, Colombia ranked #51 globally with a total of 6 clinical trials. This figure is relatively low compared to regional peers, indicating challenges in attracting clinical research investments. Factors influencing this statistic include Colombia's developing healthcare infrastructure and a growing focus on improving regulatory frameworks to enhance research capabilities.

7

Botswana

In 2009, Botswana ranked #86 globally with a total of 1 clinical trial. This number is significantly lower than many of its neighbors, indicating limited clinical research activity in the region. Factors contributing to this low figure include a relatively small population and limited investment in healthcare research infrastructure, which hampers the capacity for conducting clinical trials.

8

Kenya

In 2009, Kenya ranked #53 globally with a total of 6 clinical trials. This figure is relatively low compared to leading countries in clinical research, reflecting a significant gap in the region where nations like South Africa lead with a higher number of trials. Key factors influencing Kenya's clinical trial landscape include its growing pharmaceutical sector and increasing investment in healthcare infrastructure, which aim to enhance research capabilities and attract more international studies.

9

Mongolia

Mongolia ranked #101 globally with 1 clinical trial in 2009, placing it among the lowest in the world for this metric. In comparison, countries like Japan, which leads in clinical trials, highlight the disparity in research activity in the region. The limited number of clinical trials in Mongolia can be attributed to its smaller population and underdeveloped healthcare infrastructure, which restricts both funding and participation in research initiatives.

10

Benin

In 2009, Benin ranked #93 globally with a total of 1 clinical trial. This figure is notably low compared to other countries in West Africa, where nations like Nigeria and Ghana have significantly higher numbers of clinical trials. Factors contributing to this limited activity include a lack of funding for research, underdeveloped healthcare infrastructure, and a smaller population, which collectively hinder the country's capacity to attract clinical research initiatives.

Analysis & Context

In 2009, the United States led the world in the Number of Clinical Trials, conducting a total of 4,031 trials, while the global range spanned from a minimum of 1 trial to this maximum. The median number of trials across 107 countries was 6, highlighting a significant disparity in clinical research activity.

Global Leaders in Clinical Trials

The dominance of the United States in clinical trials is a testament to its robust healthcare infrastructure and significant investment in medical research. With 4,031 trials, it far exceeded other nations, reflecting its role as a global hub for pharmaceutical innovation and development. Following the U.S., Canada and Germany each conducted 373 trials, showcasing their strong healthcare systems and emphasis on research and development. France and the United Kingdom also featured prominently, with 305 and 246 trials respectively, underscoring their commitment to advancing medical science through clinical research.

Factors Influencing Clinical Trial Activity

The concentration of clinical trials in certain countries can often be attributed to economic strength, healthcare infrastructure, and supportive government policies. For instance, countries like Brazil and China, with 185 and 169 trials respectively, have been investing heavily in expanding their healthcare capabilities and fostering environments conducive to research. Japan and South Korea, with 166 and 164 trials, benefit from advanced healthcare systems and a cultural emphasis on innovation. Conversely, nations with fewer trials, such as Haiti and Sri Lanka with only 1 trial each, often face economic and logistical challenges that limit their capacity to conduct extensive clinical research.

Year-over-Year Changes and Trends

Analyzing the year-over-year changes in clinical trials reveals significant growth in certain regions. The United States saw an increase of 475 trials, reflecting a 13.4% growth, driven by ongoing advancements in biotechnology and pharmaceuticals. France and China also experienced substantial increases, with 67 and 65 additional trials, corresponding to growth rates of 28.2% and 62.5% respectively. These trends suggest a global shift towards increased investment in medical research, particularly in emerging economies.

Conversely, some countries saw declines in trial numbers. Australia experienced a reduction of 15 trials, a significant 16.3% decrease, potentially due to regulatory hurdles or shifts in research priorities. Similarly, Italy and Mexico faced declines, with reductions of 13 and 6 trials respectively, indicating possible economic or administrative challenges impacting their clinical research landscapes.

Implications for Global Health Research

The distribution of clinical trials reflects broader trends in global health research and development. Countries with high numbers of trials, such as the United States, Germany, and Canada, are positioned as leaders in medical innovation, influencing global health outcomes through the development of new treatments and therapies. Meanwhile, the limited activity in nations with fewer trials highlights the need for international collaboration and support to build research capacity in underrepresented regions.

Ultimately, the data from 2009 underscores the critical role of clinical trials in advancing global health and the need for equitable distribution of research efforts to address health challenges worldwide.

Frequently Asked Questions About Number of Clinical Trials in 2009

Which country had the highest number of clinical trials in 2009?

The United States had the highest number of clinical trials in 2009, with a total of 4,031 trials.

Which country had the lowest number of clinical trials in 2009?

Haiti had the lowest number of clinical trials in 2009, with only 1 trial conducted.

What was the average number of clinical trials conducted by countries in 2009?

The average number of clinical trials conducted by countries in 2009 was 75.91.

What was the median number of clinical trials conducted by countries in 2009?

The median number of clinical trials conducted by countries in 2009 was 6.

How many countries were included in the dataset for clinical trials in 2009?

The dataset for clinical trials in 2009 included 107 countries.

Which countries were in the top 10 for the number of clinical trials conducted in 2009?

The top 10 countries for the number of clinical trials conducted in 2009 were the United States, Canada, Germany, France, the United Kingdom, Brazil, China, Japan, South Korea, and Denmark.

Data Source

Number of clinical trials | ClinicalTrials.gov via Our World in Data

Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".

Visit Data Source

Cite this page

Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2009. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2009

The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.

›Embed this ranking on your site

Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.

Preview

Historical Data by Year

Explore Number of Clinical Trials data across different years. Compare trends and see how statistics have changed over time.